FDA Approves X4 Pharmaceuticals' Mavorixafor As First Therapy For Rare Immunodeficiency Disorder FDA approves Xolremdi capsules for WHIM syndrome, boosting neutrophil & lymphocyte counts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback